|
|
Year-end report |
|
|
New study shows significant improved clinical accuracy with Nevisense for both US and German dermatologists |
|
|
SciBase continues US expansion, on-boards Several US Dermatology Practices that Specialize in Skin Cancer Detection |
|
|
New review article highlights Nevisense effectiveness in identifying malignant skin lesions |
|
|
Recalculation of warrants of series TO 2 following rights issue |
|
|
Nevisense (EIS) included in updated German (S1) imaging guidelines. |
|
|
SciBase announces final outcome of directed issue and rights issue |
|
|
SciBase announces outcome of directed issue and preliminary outcome of rights issue |
|
|
The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot |
|
|
Today the subscription period in SciBase rights issue begins |
